Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 47, 2013, Pages 19125-19130

  Khalaj, Anna J ^a   Yoon, Jaehee ^a   Nakai, Jaspreet ^a   Winchester, Zachary ^a   Moore, Spencer M ^a   Yoo, Timothy ^a   Martinez Torres, Leonardo ^a   Kumar, Shalini ^b   Itoh, Noriko ^a   Tiwari Woodruff, Seema Kaushalya ^a,b,c  

^a Multiple Sclerosis Program   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIARYLPROPIONITRILE; ESTROGEN RECEPTOR BETA; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; ELECTROPHYSIOLOGY; FEMALE; GENE DELETION; GRAY MATTER; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNOCKOUT GENE; MALE; MOUSE; MYELINATION; NERVE CONDUCTION; NERVE FIBER; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REMYELINIZATION; SIGNAL TRANSDUCTION; SPLEEN CELL; UTERUS WEIGHT; WHITE MATTER;

DIFFERENTIATION; PROLIFERATION; REMYELINATION;

ANIMALS; CELL LINEAGE; ESTROGEN RECEPTOR BETA; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NITRILES; OLIGODENDROGLIA; PROPIONATES; SPINAL CORD;

EID: 84888122116     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1311763110     Document Type: Article

References (33)

1. Kumar S, et al. (2013) Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis. Neurobiol Dis 56:131-144.
2. Crawford DK, et al. (2010) Oestrogen receptor beta ligand: A novel treatment to enhance endogenous functional remyelination. Brain 133(10-2999-3016.
3. Tiwari-Woodruff S, Voskuhl RR (2009) Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice. J Neurol Sci 286(1-2-81-85.
4. Tiwari-Woodruff S, Morales LB, Lee R, Voskuhl RR (2007) Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc Natl Acad Sci USA 104(37-14813-14818.
5. Caringella AM, Di Naro E, Loverro G (2011) [Clinical function of estrogen receptors in endometrial cancer]. Minerva Ginecol 63(6-495-504.
6. Platania P, et al. (2003) Differential expression of estrogen receptors alpha and beta in the spinal cord during postnatal development: Localization in glial cells. Neuroendocrinology 77(5-334-340.
7. Narayanan SP, Flores AI, Wang F, Macklin WB (2009) Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. J Neurosci 29(21- 6860-6870.
8. Tyler WA, et al. (2009) Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation. J Neurosci 29(19-6367-6378.
9. Harrington EP, et al. (2010) Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination. Ann Neurol 68(5-703-716.
10. Dupont J, Karas M, LeRoith D (2000) The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components. J Biol Chem 275(46-35893-35901.
11. Antal MC, Krust A, Chambon P, Mark M (2008) Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutant. Proc Natl Acad Sci USA 105(7-2433-2438.
12. Campbell L, et al. (2010) Estrogen promotes cutaneous wound healing via estrogen receptor beta independent of its antiinflammatory activities. J Exp Med 207(9- 1825-1833.
13. Spence RD, et al. (2011) Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc Natl Acad Sci USA 108(21-8867-8872.
14. Harris HA, et al. (2003) Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 144(10-4241-4249.
15. Mangiardi M, et al. (2011) An animal model of cortical and callosal pathology in multiple sclerosis. Brain Pathol 21(3-263-278.
16. Flores AI, et al. (2008) Constitutively active Akt induces enhanced myelination in the CNS. J Neurosci 28(28-7174-7183.
17. Bibollet-Bahena O, Almazan G (2009) IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways. J Neurochem 109(5-1440-1451.
18. Zhou Q, Wang S, Anderson DJ (2000) Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 25(2- 331-343.
19. Meijer DH, et al. (2012) Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2. Nat Rev Neurosci 13(12-819-831.
20. Schüller U, Ruiter M, Herms J, Kretzschmar HA, Grasbon-Frodl E (2008) Absence of mutations in the AKT1 oncogene in glioblastomas and medulloblastomas. Acta Neuropathol 115(3-367-368.
21. Krege JH, et al. (1998) Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 95(26-15677-15682.
22. Meltser I, et al. (2008) Estrogen receptor beta protects against acoustic trauma in mice. J Clin Invest 118(4-1563-1570.
23. Wang L, Andersson S, Warner M, Gustafsson JA (2001) Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc Natl Acad Sci USA 98(5- 2792-2796.
24. Brown CM, Mulcahey TA, Filipek NC, Wise PM (2010) Production of proinflammatory cytokines and chemokines during neuroinflammation: Novel roles for estrogen receptors alpha and beta. Endocrinology 151(10-4916-4925.
25. Morales LB, et al. (2006) Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J Neurosci 26(25- 6823-6833.
26. Du S, Sandoval F, Trinh P, Voskuhl RR (2010) Additive effects of combination treatment with anti-inflammatory and neuroprotective agents in experimental autoimmune encephalomyelitis. J Neuroimmunol 219(1-2-64-74.
27. Spence RD, et al. (2013) Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERalpha signaling on astrocytes but not through ERbeta signaling on astrocytes or neurons. J Neurosci 33(26-10924-10933.
28. Saijo K, Collier JG, Li AC, Katzenellenbogen JA, Glass CK (2011) An ADIOL-ERβ-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 145(4-584-595.
29. Chao MV (2003) Neurotrophins and their receptors: A convergence point for many signalling pathways. Nat Rev Neurosci 4(4-299-309.
30. Cellerino A, Carroll P, Thoenen H, Barde YA (1997) Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor. Mol Cell Neurosci 9(5-6-397-408.
31. Djalali S, et al. (2005) Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development. J Neurochem 92(3-616-627.
32. Song F, et al. (2013) Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: Differential expression of neurotrophic and gliotrophic factors. J Neuroimmunol 262(1-2-11-18.
33. Linker RA, et al. (2010) Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: Therapeutic implications in a model of multiple sclerosis. Brain 133(Pt 8-2248-2263.